Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations

Epidemiology

Volumn 22, Issue 2, 2011, Pages 199-207

  Weinberger, Daniel M ^a   Harboe, Zitta B ^b   Flasche, Stefan ^c,d   Scott, J Anthony ^e   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b STATENS SERUM INSTITUT   (Denmark)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^e KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; HUMAN; INFECTION PREVENTION; PNEUMOCOCCAL INFECTION; PREVALENCE; PRIORITY JOURNAL; SEROTYPE;

ENGLAND; FEMALE; FORECASTING; HUMANS; IMMUNIZATION; KENYA; MALE; MODELS, STATISTICAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINES, CONJUGATE; WALES;

EID: 79951562388     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182087634     Document Type: Article

References (34)

1. Bogaert D, Sluijter M, Toom N, et al. Dynamics of pneumococcal colonization in healthy Dutch children. Microbiol. 2006;152:377-385. (Pubitemid 43210669)
2. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis. 2004;190:1203-1211. (Pubitemid 39287745)
3. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med. 2009;6:e1000081.
4. Weinberger DM, Harboe ZB, Sanders EA, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis. 2010;51:692-699.
5. Hausdorff William P, Bryant J, Paradiso Peter R, Siber George R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use: part I. Clin Infect Dis. 2000;30:100-121. (Pubitemid 30067069)
6. Scott J, Hall A, Dagan R, et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex and geography in 7000 episodes of invasive disease. Clin Infect Dis. 1996;22:973-981. (Pubitemid 26260598)
7. Harboe ZB, Benfield Thomas L, Valentiner-Branth P, et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. 2010;50:329-337.
8. Kellner James D, Vanderkooi Otto G, MacDonald J, Church Deirdre L, Tyrrell Gregory J, Scheifele David W. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary Area Streptococcus pneumoniae Research (CASPER) study. Clin Infect Dis. 2009;49:205-212.
9. Pilishvili T, Lexau C, Farley Monica M, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate. Vaccine. 2010; 201:32-41.
10. Huang SS, Hinrichsen VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on serotypes, antibiotic resistance, and risk factors for carriage in young children. Pediatrics. 2009;124:e1-e11.
11. Wenger JD, Zulz T, Bruden D, et al. Invasive pneumococcal disease in Alaskan children: impact of the seven-valent pneumococcal conjugate vaccine and the role of water supply. Pediatr Infect Dis J. 2010;29:251-256.
12. Isaacman D, McIntosh E, Reinert R. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumo-coccal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:197-209.
13. Sleeman KL, Griffiths D, Shackley F, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis. 2006;194:682-688. (Pubitemid 44297855)
14. Sjostrom K, Spindler C, Ortqvist A, et al. Clonal and capsular types decide whether Pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis. 2006;42:451-459. (Pubitemid 43202515)
15. Weinberger DM. Risk of death from pneumococcal pneumonia is a stable serotype-associated property: a meta-analysis. In: 7th International Symposium on Pneumococci and Pneumococcal Diseases; 2010; (Tel-Aviv), Israel.
16. Weinberger DM, Trzcinski K, Lu YJ, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 2009;5:e1000476.
17. Hicks Lauri A, Harrison Lee H, Flannery B, et al. Incidence of pneu-mococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. 2007;196:1346-1354. (Pubitemid 351412007)
18. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 2003;187:1424-1432. (Pubitemid 36549688)
19. Abdullahi O, Nyiro J, Lewa P, Slack M, Scott JA. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae naso-pharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J. 2008;27:59-64. Doi: 10.1097/INF.0b013e31814da70c.
20. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA. Post-PCV7 changes in colonizing pneumococcal sero-types in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005;116:e408-e413. (Pubitemid 44336655)
21. Venkateswaran P, Stanton N, Austrian R. Type variation of strains of Streptococcus pneumoniae in capsular serogroup 15. J Infect Dis. 1983;147:1041-1054. (Pubitemid 13068350)
22. Van Selm S, van Cann LM, Kolkman MA, van der Zeijst BA, van Putten JP. Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect Immun. 2003;71:6192-6198. (Pubitemid 37337674)
23. Weinberger DM, Harboe ZB, Sanders EAM, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis. 2010;51:692-699.
24. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med. 2009;6:e1000081.
25. Vestrheim DF, Hoiby EA, Aaberge IS, Caugant DA. Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway. Clin Vaccine Immunol. 2010;17:325-334.
26. Hussain M, Melegaro A, Pebody R, et al. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect. 2005;133:891-898. (Pubitemid 41478975)
27. Miller E. Post-PCV serotype changes and variability in observations. In: 7th International Symposium on Pneumococci and Pneumococcal Diseases; 2010; (Tel Aviv), Israel.
28. Brueggemann AB, Spratt BG. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol. 2003;41:4966-4970. (Pubitemid 37429903)
29. Blomberg C, Dagerhamn J, Dahlberg S, et al. Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae. J Infect Dis. 2009;199:1032-1042.
30. Obert C, Sublett J, Kaushal D, et al. Identification of a candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease. Infect Immun. 2006;74:4766-4777. (Pubitemid 44157264)
31. Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis. 2002;35:547-555.
32. Finland M, Barnes MW. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City hospital during selected years between 1935 and 1974. J Clin Microbiol. 1977;5:154-166.
33. Hausdorff WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet. 2001;357:950-952. (Pubitemid 32247290)
34. Obaro S. Differences in invasive pneumococcal serotypes. Lancet. 2001;357:1800-1801.